Enliven Therapeutics (ELVN)

Enliven Therapeutics (ELVN) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• ELVN last traded at $44.32, 0.16% on the day.
• Enliven Therapeutics: P/E -27.0.
• Over the past year ELVN returned 84.90%; year to date 187.79%.

Updated 2026-11-02 18:02 UTC